Other OTC - Delayed Quote • USD
Deltagen Inc. (DGEN)
At close: January 29 at 2:48 PM EST
Key Executives
Amounts are as of December 31, 2006 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Robert J. Driscoll | CEO, President, Secretary & Director | 411k | -- | 1966 |
Mr. Daniel Ratto | Chief Financial Officer | 105.3k | -- | 1958 |
Deltagen Inc.
1900 South Norfolk Street
Suite 105
San Mateo, CA 94403
United States
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
Description
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
Corporate Governance
Deltagen Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- May 31, 2007Dividend Date
- May 17, 2007Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available